R&D facility
Dec 06, 2018
Roche signs Icagen; UCB devote $255M; Siemens Healthineers celebrates
Roche signs Icagen in neuro drug discovery deal worth up to USD 274 Million Roche and Icagen have signed a licensing and collaboration deal regarding ion channel modulators for neurological disorders. Icagen receives up to USD 274 million in development and commercial milestones. The duo will work on small molecules...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
